Pharm-Olam is currently partnering with a sponsor company in the development of a treatment for Glioblastoma / Anaplastic Astrocytoma.
Pharm-Olam is currently partnering with a sponsor company in the development of a treatment for Glioblastoma / Anaplastic Astrocytoma.
1 PagesExperience & Insights Pharm-Olam’s Oncology team is le d by Dr. Dhiraj Abhyankar, a Medical Oncologist with over 15 years of experience at both pharmaceutical and clinical research organizations. With more than 25% of Pharm-Olam’s total study portfolio in Oncology- related studies, Pharm-Olam was the right partner for this specialized trial. About Pharm-Olam International A multinational Contract Research Organization (CRO), Pharm-Olam offers comprehensive clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering high-quality data, achieving targeted enrollment and meeting projected timelines. Pharm-Olam makes clinical research....Easy As I, II, III, IV TM . Study Overview A Phase II/II
